Insurers won’t cover new Alzheimer’s treatment for some customers
Private insurers in certain states are refusing to cover the newly approved Alzheimer's drug Leqembi, considering it experimental, while Medicare ...
Private insurers in certain states are refusing to cover the newly approved Alzheimer's drug Leqembi, considering it experimental, while Medicare ...